The convenience of ordering medicines online has attracted millions, especially the elderly. While it may have made life easier for patients, questions have cropped up, leading up to a clash between corporate titans that run online pharmacies and an influential trade body of chemists. The gloves are off, as the likes of Reliance, Tata, Flipkart, and Amazon have acquired or set up online-pharmacy businesses, investing billions of dollars to build
Related Posts
Data-integrity woes have come back to haunt Indian pharma. How can it deal with the USFDA’s glare?
Regulatory lapses have been hurting the industry since long. In several instances earlier, such issues had eroded the financials of top-tier companies. Of late, many companies have again come under the USFDA’s lens. Why has one of the world’s leading suppliers of medicines not learnt from its past, and how can it get its act […]
This Ichnos Glenmark drug promises to BEAT cancer, affordably. Can it challenge Big Pharma?
Cyril Konto, CEO, Ichnos Glenmark Innovation and Glenn Saldanha, CMD, Glenmark Pharma; image credit: Glenmark. Synopsis The drug has given promising results for the treatment of multiple myeloma, a rare form of blood cancer. The market for such drugs is expected to touch USD30 billion by the end of the decade. Although these are early […]
A new lease of life: How India’s first CAR-T cell therapy is helping patients battle cancer.
The ImmunoACT team that worked on India’s first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT Synopsis NexCAR 19, India’s first cell therapy to treat a specific form of blood cancer, is showing encouraging results. Now listed at 40 hospitals across the country, its indigenous maker, ImmunoACT, is driving a medical revolution. Can the battle […]
